Nath Bio-Genes (India) Ltd
Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]
- Market Cap ₹ 303 Cr.
- Current Price ₹ 158
- High / Low ₹ 264 / 138
- Stock P/E 7.96
- Book Value ₹ 339
- Dividend Yield 1.27 %
- ROCE 6.79 %
- ROE 6.07 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.47 times its book value
- Debtor days have improved from 127 to 88.9 days.
Cons
- Tax rate seems low
- Company has a low return on equity of 6.16% over last 3 years.
- Contingent liabilities of Rs.92.4 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
97 | 109 | 230 | 234 | 248 | 365 | |
82 | 89 | 193 | 185 | 198 | 315 | |
Operating Profit | 15 | 20 | 37 | 49 | 50 | 50 |
OPM % | 15% | 18% | 16% | 21% | 20% | 14% |
1 | 1 | -87 | 1 | 4 | 5 | |
Interest | 2 | 4 | 11 | 10 | 9 | 10 |
Depreciation | 5 | 5 | 3 | 3 | 3 | 4 |
Profit before tax | 9 | 12 | -63 | 36 | 42 | 41 |
Tax % | -1% | 4% | 6% | 3% | 5% | 5% |
9 | 12 | -67 | 35 | 40 | 39 | |
EPS in Rs | 5.75 | 7.34 | -35.46 | 18.43 | 20.85 | 20.31 |
Dividend Payout % | 0% | 0% | -6% | 11% | 10% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 17% |
TTM: | 47% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 17% |
TTM: | 5% |
Stock Price CAGR | |
---|---|
10 Years: | 2% |
5 Years: | -9% |
3 Years: | -12% |
1 Year: | -25% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 16 | 16 | 19 | 19 | 19 | 19 |
Reserves | 30 | 41 | 523 | 554 | 591 | 625 |
11 | 19 | 93 | 105 | 110 | 122 | |
63 | 82 | 105 | 114 | 160 | 259 | |
Total Liabilities | 120 | 158 | 739 | 793 | 880 | 1,026 |
21 | 38 | 245 | 244 | 249 | 250 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 1 | 0 | 5 | 5 | 6 | 6 |
99 | 121 | 490 | 543 | 625 | 770 | |
Total Assets | 120 | 158 | 739 | 793 | 880 | 1,026 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
17 | 38 | 75 | ||||
-20 | -3 | -27 | ||||
-22 | -2 | -8 | ||||
Net Cash Flow | -25 | 34 | 39 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 47 | 70 | 136 | 152 | 139 | 89 |
Inventory Days | 587 | 667 | 4,388 | |||
Days Payable | 146 | 239 | 586 | |||
Cash Conversion Cycle | 487 | 499 | 136 | 3,954 | 139 | 89 |
Working Capital Days | 109 | 122 | 573 | 579 | 497 | 345 |
ROCE % | 24% | 7% | 7% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Investor Presentation
2h - Investor Presentation on Audited Financial Results as on 31st March 2025
- Financial Results As On 31St March 2025 2h
-
Board Meeting Outcome for Outcome Of Board Meeting
2h - Approved FY25 results, Rs.2 dividend, director changes, auditor appointments, AGM on Aug 22, 2025.
-
Intimation Of Earning Conference Call.
24 Apr - Earnings conference call scheduled for April 30, 2025, at 4 PM IST for Q4 & FY25 results.
-
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31St March 2025
21 Apr - Board meeting on April 29 to approve FY25 results and consider dividend recommendation.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
Concalls
-
Apr 2025TranscriptNotesPPT
-
Jan 2025TranscriptNotesPPT
-
Oct 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPT
-
Oct 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Apr 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
Apr 2019TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into